What's Happening?
Researchers from The University of Hong Kong have developed a new blood test, powered by artificial intelligence, that can predict a person's risk of developing serious heart and circulatory diseases up to 15 years before symptoms appear. The tool, named
CardiOmicScore, analyzes a single blood sample to estimate future risks for six major cardiovascular conditions, including coronary artery disease and stroke. The test utilizes a multiomics approach, combining genomics, proteomics, and metabolomics to decode complex molecular signals. This method allows for the detection of early shifts in immune activity, metabolism, and blood vessel health, which are not typically captured by traditional risk assessments based on age, blood pressure, and smoking history.
Why It's Important?
The development of CardiOmicScore represents a significant advancement in cardiovascular disease prevention. By identifying risks much earlier, the tool offers the potential to change the trajectory of disease through timely lifestyle modifications and early prevention. This could lead to a reduction in the number of deaths caused by cardiovascular diseases, which remain the leading cause of death worldwide. The AI-driven approach also addresses limitations of genetic testing, which cannot account for changes in risk due to lifestyle and environmental factors. By providing a dynamic assessment of current health, CardiOmicScore could enable more personalized and preventive healthcare strategies.
What's Next?
While the CardiOmicScore shows promise, it must undergo further validation before it can be widely adopted in clinical practice. The model was primarily developed using data from the U.K. Biobank and has not yet been independently validated. Future steps include ensuring the tool's accuracy across diverse patient populations and determining its ability to lead to actionable care decisions. If successful, this technology could become a standard part of cardiovascular risk assessment, offering a more predictive and personalized approach to patient care.
